Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,375 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,000

Underlying: Common Stock · 29,375 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,444,517

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 16,675 $84.07 $1,401,867.25
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,352.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $83.50 to $84.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,027.82

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 3,100 $84.66 $262,446.00
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,527.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $84.51 to $85.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 100 $85.26 $8,525.50
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,627.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

Read SEC document
September 22, 2022 Filed Sep 22, 2022 22:28 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 29,375 $35.20 $1,033,903.06
Disclosure

SEC source: 0001225208-22-010422 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,727.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

Read SEC document
September 08, 2022 Filed Sep 8, 2022 21:49 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,725 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-010183 · doc4.xml · derivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,075

Underlying: Common Stock · 6,725 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 08, 2022 Filed Sep 8, 2022 21:49 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 6,725 $90.94 $611,571.50
Disclosure

SEC source: 0001225208-22-010183 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,560.7842

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
September 08, 2022 Filed Sep 8, 2022 21:49 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 6,725 $35.20 $236,697.81
Disclosure

SEC source: 0001225208-22-010183 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,285.7842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
September 06, 2022 Filed Sep 6, 2022 22:40 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,242 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-22-010085 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,720

Underlying: Common Stock · 7,242 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2022 Filed Sep 6, 2022 22:40 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 7,242 $89.00 $644,538.00
Disclosure

SEC source: 0001225208-22-010085 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,231.8049

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Read SEC document
September 06, 2022 Filed Sep 6, 2022 22:40 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,242 $36.75 $266,143.50
Disclosure

SEC source: 0001225208-22-010085 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,473.8049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,375 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,375

Underlying: Common Stock · 29,375 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,435,017

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 15,773 $104.92 $1,654,903.16
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,352.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $104.39 to $105.33. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,125.82

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 4,002 $104.03 $416,328.06
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,625.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $103.36 to $104.36. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 100 $105.41 $10,541.00
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,627.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 23:55 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 29,375 $35.20 $1,033,903.06
Disclosure

SEC source: 0001225208-22-009571 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,727.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,725 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-009404 · doc4.xml · derivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,800

Underlying: Common Stock · 6,725 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 6,725 $105.01 $706,192.25
Disclosure

SEC source: 0001225208-22-009404 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,560.7842

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 6,725 $35.20 $236,697.81
Disclosure

SEC source: 0001225208-22-009404 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,285.7842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,242 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-22-009403 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,962

Underlying: Common Stock · 7,242 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 5,324 $104.59 $556,856.86
Disclosure

SEC source: 0001225208-22-009403 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,231.8049

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F3 · price: This transaction was executed in multiple trades at prices ranging from $104.01 to $104.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 1,918 $105.03 $201,447.16
Disclosure

SEC source: 0001225208-22-009403 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,555.8049

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $105.01 to $105.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 22:16 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 7,242 $36.75 $266,143.50
Disclosure

SEC source: 0001225208-22-009403 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,473.8049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

Read SEC document
August 09, 2022 Filed Feb 13, 2023 23:33 UTC
Ullem Scott B.CVP, Chief Financial Officer
GiftCommon Stock 13,083 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001811 · doc5.xml · nonDerivative · entry 2

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 257,822

Read SEC document
August 09, 2022 Filed Feb 13, 2023 23:33 UTC
Ullem Scott B.CVP, Chief Financial Officer
GiftCommon Stock 13,083 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-001811 · doc5.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,178

Read SEC document
August 05, 2022 Filed Aug 5, 2022 22:05 UTC SaleCommon Stock 4,811 $103.66 $498,708.26
Disclosure

SEC source: 0001225208-22-009330 · doc4.xml · nonDerivative · entry 1

Zovighian Bernard J · CIK 0001665141 · CVP, TMTT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,246.9647

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2021.

Read SEC document
August 02, 2022 Filed Aug 3, 2022 00:23 UTC
Chopra DaveenCVP, Surgical Structural Heart
SaleCommon Stock 1,000 $102.49 $102,490.00
Disclosure

SEC source: 0001225208-22-009141 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, Surgical Structural Heart

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,911

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,375 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,750

Underlying: Common Stock · 29,375 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 6

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Living Trust

Disclosed balance after: 3,425,517

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
GiftCommon Stock 9,500 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,352.82

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 7,951 $96.87 $770,213.37
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,852.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F4 · price: This transaction was executed in multiple trades at prices ranging from $96.330 to $97.120. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 6,000 $94.56 $567,360.00
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,803.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $94.170 to $95.130. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 5,924 $95.89 $568,052.36
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,803.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

F2 · price: This transaction was executed in multiple trades at prices ranging from $95.315 to $96.310. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 14, 2022 Filed Jul 15, 2022 00:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 29,375 $35.20 $1,033,903.06
Disclosure

SEC source: 0001225208-22-008783 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,727.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2022.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 3,675 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-008744 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,725

Underlying: Common Stock · 3,675 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 3,675 $97.60 $358,680.00
Disclosure

SEC source: 0001225208-22-008744 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,381.2782

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 3,675 $35.20 $129,347.87
Disclosure

SEC source: 0001225208-22-008744 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,056.2782

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,725 $0.00 Strike: $35.20 $0.00
Disclosure

SEC source: 0001225208-22-008745 · doc4.xml · derivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,525

Underlying: Common Stock · 6,725 shares

Expires 2023-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 6,725 $97.60 $656,360.00
Disclosure

SEC source: 0001225208-22-008745 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,560.7842

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
July 08, 2022 Filed Jul 8, 2022 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 6,725 $35.20 $236,697.81
Disclosure

SEC source: 0001225208-22-008745 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,285.7842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 00:14 UTC
Szyman Catherine M.CVP, Critical Care
GrantCommon Stock 2,032 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-008720 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,374.498

F1 · shares: These restricted stock units were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Read SEC document
July 07, 2022 Filed Jul 12, 2022 00:04 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
GrantPerformance Rights · Derivative 7,625 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-008764 · doc4.xml · derivative · entry 3

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,625

Underlying: Common Stock · 7,625 shares

Expires not disclosed

F3 · derivative.exercise_price: Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

F3 · derivative.expiration_date: Reflects the target number of shares (the Target Award) covered by restricted stock units granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on July 7, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

Read SEC document
July 07, 2022 Filed Jul 12, 2022 00:04 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
GrantEmployee Stock Option (Right to Acquire) · Derivative 54,500 $0.00 Strike: $98.43 $0.00
Disclosure

SEC source: 0001225208-22-008764 · doc4.xml · derivative · entry 2

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,500

Underlying: Common Stock · 54,500 shares

Expires 2029-07-06

F2 · derivative.exercise_date: These options were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.

Read SEC document
July 07, 2022 Filed Jul 12, 2022 00:04 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
GrantCommon Stock 6,100 $0.00 $0.00
Disclosure

SEC source: 0001225208-22-008764 · doc4.xml · nonDerivative · entry 1

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,874.8696

F1 · shares: These restricted stock units were granted on July 7, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 00:59 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,242 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-22-008534 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,204

Underlying: Common Stock · 7,242 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2022 Filed Jul 6, 2022 00:59 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 7,242 $95.90 $694,486.07
Disclosure

SEC source: 0001225208-22-008534 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,231.8049

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2021.

F2 · price: This transaction was executed in multiple trades at prices ranging from $95.205 to $95.910. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.